Skip to main content
. 2017 Dec 20;9(5):5834–5847. doi: 10.18632/oncotarget.23533

Figure 6. B cell frequency, CD39, and CD73 expression were evaluated in a second cohort of 14 patients with adjuvant CRT and 24 normal controls.

Figure 6

(A) Boxplots show the frequency of B cells before and after CRT. The expression of CD39 and CD73 is decreased after CRT. (B) Course of B cell frequency correlated with time after CRT (2–23 months).